#United States #Washington #hemp industry #Morgan Griffith #CBD Regulation

ONE HEMP’s Support for Representative Morgan Griffith

In a significant move for the hemp industry, ONE HEMP, a coalition of leading industry figures, publicly applauded Representative Morgan Griffith (R-VA) for his recent initiative introducing draft legislation aimed at regulating hemp-derived cannabinoid products. This legislative proposal is a crucial advancement in creating a comprehensive federal framework that not only safeguards consumers but also supports responsible business practices within the hemp market.

Bill Stoufer, President of Balanced Health Botanicals and a member of One Hemp, emphasized the importance of this legislative action, stating, "Representative Griffith deserves recognition for taking decisive action to advance federal oversight in the hemp industry. The hemp industry was built on meeting real consumer needs, and it's time every company is held to that standard. This bill supports essential guardrails that will protect public health and ensure the industry’s integrity."

The draft legislation encompasses several pivotal provisions crucial for improving market standards. Among these are:

• - Packaging and labeling requirements: This is aimed at ensuring that all hemp products are transparently labeled, providing consumers with essential information about what's inside.
• - Manufacturing and testing standards: Introducing strict guidelines for producing and testing hemp products will enhance product safety and quality.
• - Facility registration: This requirement will help track manufacturers, further ensuring that only qualified companies can produce hemp products.
• - Direction for Health and Human Services (HHS) to establish a total cannabinoid cap within 60 days of enactment: This is aimed at preventing any potential over-concentration of cannabinoids in consumables.

CEO of Charlotte's Web Inc., Bill Morachnick, another key player in One Hemp, expressed his gratitude towards Griffith's leadership, noting that this legislative proposal is a vital step towards purifying the hemp industry landscape and ensuring consumers have access to safe, high-quality products.

"We believe balanced regulation is essential to unlock the full economic and public health potential of hemp," stated Morachnick. He reiterated the coalition's commitment to work alongside Griffith, federal entities, and other industry stakeholders to ensure that the final regulatory framework is rooted in scientific evidence and prioritizes consumer interests.

About ONE HEMP

ONE HEMP is an industry-led working group dedicated to establishing science-based regulatory standards for hemp-derived cannabinoid products. With a focus on consumer safety, product integrity, and innovation, the coalition comprises leading cannabinoid researchers and toxicologists who aim to align their efforts with rigorous scientific standards and understand CBD’s safety profile.

The coalition’s mission is to advocate for a federal regime that classifies CBD products as dietary supplements and establishes uniform standards across the supply chain. By aiming to promote transparency, accountability, and trust, ONE HEMP seeks to ensure that all companies operating in the hemp sector uphold the value consumers expect and deserve.

In conclusion, ONE HEMP’s partnership with key federal figures signals a pivotal point for the hemp industry. As they forge ahead, the coalition aims to cultivate a regulatory environment that not only benefits consumers but also positions hemp as a significant player in the market, driving forward economic growth and public health initiatives.